Tag: Obstructive Sleep Apnea
Signifier receives significant investment
March 24, 2022HME News Staff
BOSTON – Signifier Medical Technologies, a Boston-based medical technology company, has announced that Waha Capital PJSC, Angelus Sano Fund L.P., Segulah Medical Acceleration AB and certain other individual investors have collectively invested approximately $49 million in the purchase of existing shares in the company from shareholders unrelated to the board and management. Signifier's eXciteOSA medical device for the treatment of sleep disordered breathing has been launched in...
ResMed survey outlines what’s keeping Americans up at night
March 15, 2022HME News Staff
SAN DIEGO – About 52% of Americans reported snoring or being told they snore, but only 33% are concerned about the associated health implications, according to ResMed’s 2022 Global Sleep Surveys.
“Sleep quality can be impacted by lifestyle changes and poor habits, but many people are struggling with undiagnosed conditions that may be the root cause,” said Carlos M. Nunez, M.D., ResMed’s chief medical officer. “Sleep apnea is a serious health concern, but...
AirAvant tapped to serve veterans
November 2, 2021HME News Staff
DEERFIELD, Fla. – AirAvant Medical and First Nation Group have partnered to provide the FDA-cleared Bongo Rx Expiratory Positive Airway Pressure device to veterans and active-duty military members suffering from obstructive sleep apnea. First Nation Group is a medical-surgical supplier for all federal government agencies. “The opportunity to proudly serve veterans attracted AirAvant Medical to the partnership,” said Bruce Sher, co-president and co-founder. “It’s an honor...
ResMed buys HST company
October 4, 2021HME News Staff
SAN DIEGO – ResMed has bought Ectosense, which makes the NightOwl home sleep test.
The NightOwl, approved by the U.S. Food and Drug Administration, is currently sold in the United States, Australia, New Zealand, India and parts of Europe. ResMed has distributed the NightOwl, under the brand ResMed onesleeptest, in Australia, New Zealand and India since 2020, and has been a minority investor in Ectosense since July 2020.
"Sleep labs and home tests each have critical roles to...
Costly OSA: CDC enlists AASM in raising awareness
September 28, 2021HME News Staff
DARIEN, Ill. – The Centers for Disease Control and Prevention has awarded a grant to the American Academy of Sleep Medicine for a new awareness program focused on improving recognition of obstructive sleep apnea.
Nearly 30 million American adults have OSA and 80% are undiagnosed, costing the U.S. more than $149 billion annually in increased health care and mental health care costs, lost work productivity and increased accidents, according to a press release.
“Millions...
Sleep app puts ‘patients at the center’
August 27, 2021Tracy Orzel
DARIEN, Ill. – A proposed web-based app called “MySleepVillage” took second place in the American Academy of Sleep Medicine’s first ever Change Agents, a contest designed to generate creative ideas for diagnosing and treating obstructive sleep apnea.
The app aims to streamline patient communication and testing; connect to physicians, insurers and medical equipment companies; and provide options for remote monitoring of CPAP usage. The team behind it estimates that...
AHA releases statement on OSA and cardiovascular disease
June 29, 2021HME News Staff
YARMOUTH, Maine – Obstructive sleep apnea is often under recognized and understated in cardiovascular practice, despite its high prevalence in patients with heart diseases and the vulnerability of cardiac patients to OSA-related stressors and adverse cardiovascular outcomes, according to a new scientific statement from the American Heart Association. “We recommend screening for OSA in patients with resistant/poorly controlled hypertension, pulmonary hypertension, and recurrent atrial...
Oventus highlights DTC business
June 21, 2021HME News Staff
BRISBANE, Australia – Oventus Medical says current data indicate that 60% of all patient referrals are coming direct-to-consumer from through two websites: gopapfree.com and o2vent.com. Additionally, the company says the number of telehealth consultations scheduled has increased 25% in the current quarter compared to the previous quarter. “Since Oventus launched its telehealth initiative as a result of COVID-19, the patient funnel has captured more than 2,000 patients,” the company...
New research links untreated OSA, COVID-19 infections
June 14, 2021HME News Staff
SAN DIEGO – People with untreated obstructive sleep apnea were associated with a higher rate of COVID-19 infection than those who received PAP treatment, according to a poster presented by ResMed and Kaiser Permanente during SLEEP 2021, which was held virtually June 10-13.
The data showed a dose-response association of OSA severity on infection rate: Patients with untreated mild OSA had a COVID-19 infection rate of 2%, while patients with severe untreated OSA had a COVID-19 infection...
Oventus signs up Sleep Metrics
April 26, 2021HME News Staff
BRISBANE, Australia – Oventus Medical has signed a new virtual lab-in-lab agreement with Sleep Metrics, a Portland, Ore.-based provider of sleep apnea testing and therapy, its fourth such agreement. Through the agreement, Sleep Metrics is now able to offer O2Vent therapy as a treatment alternative to patients who refuse CPAP therapy or find it challenging. “There are tremendous synergies with our VLIL model and Sleep Metrics’ existing at-home OSA testing,”...